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Two acidic Ca 2+-binding proteins (CaBP33 and CaBP37) purified from bovine brain have been characterized in terms of immunological properties, 
heat-sensitivity, electrophoretic mobility, and Ca 2+-dependent binding to negatively charged phospholipids and to brain membranes. They were 
induced to bind to memb~nes by homogen~tion of brain tissue in the presence of CaCl,. The membrane-fund CaBP33/CaBP37 mixture resisted 
extraction with detergents and was solubilized with high concentrations of EGTA/KCl. However, apparent Ca * ‘-independent binding of the two 
proteins to membranes eemed to occur as well. This latter fraction of membrane-bound CaBP33 and CaBP37 could be solubilized with Triton 
X-100, indicating that brain membranes normally contain the two proteins as intrinsic components. 
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1. INTRODUCTION 
The second messenger calcium ion is involved in the 
regulation of a number of activities within animal cells, 
including cell division, shape changes and motility, the 
conductance and transmission of nerve impulses, secre- 
tion, and several enzymatic activities [ 11. The Ca2+ con- 
centration in the cytoplasm of resting cells is kept L 0.1 
PM by the Ca2+ pump, mitochondria, and a number of 
cytoplasmic proteins which, thanks to their high affini- 
ty for Ca” binding, act as Ca2+ buffers [I]. In addi- 
tion, cells possess a set of proteins characterized by af- 
finities for Ca’” in the range l-100 PM, which act as 
amplifiers of the Ca2+ signal. The ubiquitous in- 
tracellular Ca2+ receptor, calmodulin, is one example 
of Ca’+-binding proteins capable of amp~f~ng the 
Ca2’ signal [Zf. Calmodulin belongs to the superfamily 
of Ca2+-binding proteins thought to have evolved from 
a common ancestor and defined as Ca’+-regulatory 
proteins of the EF-hand type [2]. Other members of this 
superfamily are parvalbumin, troponin C, the intestinal 
Ca2’-binding protein, S-100 proteins, and many others 
[Z-4]. It is now becoming clear that individual cell types 
express their own set of EF-hand proteins, that this 
event is developmentally regulated, and that the uneven 
distribution of these proteins (with the exception of 
calmodulin) contributes to the specificity of individual 
cell types. The biological, physicochemical, and func- 
tional aspects of EF-hand proteins have been extensive- 
ly reviewed [2-61. 
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In recent years, a novel superfamily of Ca’+-binding 
proteins has been identified. The members of this 
superfamily share the ability to bind Ca2’ and to bind 
to membranes (phospholipids) (see [7-91 for reviews). 
On structural grounds, they are characterized by the so- 
called endonexin fold, i.e. a highly conserved cluster of 
17 amino acids that is repeated several times in in- 
dividual primary sequences. The Ca’+-binding af- 
finities of Ca”- and phospholipid-binding proteins in 
solution are not high, but increase upon binding to 
targets. This novel superfamily of Ca2+-binding pro- 
teins is now known as the annexin superfamily. 
Given the central role played by Ca2” in cellular ac- 
tivation, it would be advisable to identify, isolate, and 
characterize as many Ca’+-binding proteins as possible. 
Recently, we have identified two novel Ca*+-binding 
proteins in bovine brain [lo]. These proteins were called 
CaBP33 and CaBP37 on the basis of their molecular 
weights as estimated by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) and 
gel filtration. We show here that CaBP33 and CaBP37 
are Ca’+-dependent phospholipid- and membrane- 
binding proteins. 
2. MATERIALS AND METHODS 
The CaBP33/CaBP37 mixture was purified from bovine brain as in 
[to]. To separate the two proteins from one another, the mixture was 
loaded onto a column of DEAE Sephadex A-50 (1 x 10 cm) 
equilibrated with 20 mM Tris-HCl, pH 7.5, 5 mM 2-mercaptoethanol 
(buffer I), which was washed first with buffer I and then with buffer 
I containing 0.15 M NaCI. Finally, the column was developed with a 
linear NaCl gradient (0.15-0.30 M in buffer I, 100 ml total vol.). 
An antiserum against he mixture was raised in rabbits by mdtisite 
injection of 0.3-0.5 mg of protein in compiete Freund adjuvant, 
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foliowed by injections of proteins in incomplete adjuvant 13 and 40 
days later. An&n& were bled two weeks after the last injection. The 
specificity of the antiserum was assessed by immunoblotting [l I] US- 
ing the CaBP33KaBP37 mixture and a bovine brain cytosolic frac- 
tion. 
Binding of the CaBP33KaBP37 mixture to liposomes of different 
phospho~~pjd composition was done exactly as in 112). 
SDS-PACE (10% acrykmide~ and PAGE in the absence of SDS 
(ZCWe acrylamide) were done as in f13,14], respectively. Gels were 
stained with Coomassie blue. 
S-1OOb and S-loOa(, proteins were purified from rat brain and por- 
cine heart, respectively [15]. 
Other experimental details are given in section 3 and in the legends 
to figures. 
3. RESULTS AND DISCUSSION 
CaBP33 and CaBP37 could be separated from one 
another by DEAE Sephadex A-50 chromatography, the 
left and right tails of the ~hromatogr~ containing vir- 
tually pure CaBP33 and CaBP37, respectively 
(fig. la-c). In polyacrylamide gels run under native con- 
ditions, the unfractionated mixture migrated signi- 
ficantly slower than S-1OOb and S-lOOa proteins, as 
two distinct but poorly separated bands (fig.ld-f), as 
expected on the basis of the results illustrated in 
fig. la-c. 
The antiserum raised against he unfractianated mix- 
ture proved specific to CaBP33 and CaBP37 by im- 
rnunoblotting when tested on a bovine brain cytosolic 
fraction (fig.lg,h,g’,h’). No binding of this antiserum 
was detected when a rat lung cytosolic fraction was 
analyzed (fig.lj,j’). On the other hand, this antiserum 
recognized a 53 kDa doublet in a rat liver cytosalic frac- 
tion (fig. li,i’) and a 53 kDa polypeptide in a rat kidney 
cytosolic fraction (fig.lk,k’). 
Subjecting rat brain and porcin heart to the pro- 
cedure used to purify bovine brain CaBP33 and 
CaBP37 [LO] resulted in the purification of CaBP33 ex- 
clusively, in the case of rat brain (fig. lm), and of a mix- 
ture of CaBP33 and CaBP37 in which CaBP33 was 
predominant, in the case of porcine heart (fig.ln). Rat 
brain CaBP33 was much less immunoreactive than the 
homologous bovine brain protein, by immunoblot~ng 
(fig.lm’). In the case of porcine heart CaBP33 and 
CaBP37, the antiserum turned out to interact exclusive- 
ly with CaBP33 (fig.ln’). 
Bovine brain CaBP33 and CaBP37 proved substan- 
tially heat-stable (figJo-r,o'-r ‘1. They resisted to 
70°C for 5 min. When heated at 100°C for 5 min, the 
two proteins could be partially precipitated. The frac- 
tion of them that remained in solution did not appear to 
have undergone denaturation, since the antiCaBP33/ 
CaBP37 antiserum still bound to both proteins 
(fig.lr,r’). 
The electrophoretic mobility of the CaBP33KaBP37 
mixture in SDS gels was the same irrespective of 
whether or not 2-mercaptoethanol was present during 
boiling before electrophoresis (fig.ls,t). 
Taken together, these data indicated that CaBP33 
and CaBP37 are two distinct proteins and that CaBP33 
is not the result of limited prateolysis of CaBP37. An- 
tisera were also raised against individual proteins. 
Strong immunological cross-reactivity was detected 
(not shown), indicating homology between the two pro- 
teins. This observation, the Ca”-binding properties of 
the two proteins, and the notion that several annexins 
are characterized by M, values around 35 kDa [7-91 led 
us to investigate whether our proteins are brain annex- 
ins. To this end, two sets of experiments were done. In 
one set, the procedure used to isolate two novel 32 and 
34 kDa annexins from bovine lung 1121 was applied to 
bovine brain. Briefly, bovine brain tissue was homo- 
genized in buffer I containing 0.1 M NaCl, 5 mM 
EGTA, 0.25 mM phenylmethylsulfonyl fluoride 
(PMSF), and centrifuged at 40000 x g for 1 h at 4°C 
in a Kontron (Centrikon H-401) centrifuge. The super- 
natant was adjusted to 5 mM CaCl2 at a constant PI-I of 
7.5, incubated at 4°C for 15 min under agitation, and 
centrifuged. The pellet was washed first with the above 
medium minus EGTA plus 1 mM CaCl2, and then with 
the above medium minus NaCl and EGTA plus 1 mM 
CaC12, The final pellet was resuspended in buffer I con- 
taining 5 mM EGTA, and centrifuged at 150000 x g 
for 30 min at 4°C in a Kontron (Centrikon T 1055) cen- 
trifuge. The supernatant was analyzed for the presence 
of the CaBP33KaBP37 mixture by SDS-PAGE and 
~munoblotting~ Fig.iu,v,u’,v’ shows that he two 
proteins could be isolated by the above procedure. 
In the other set of experiments, the interaction of the 
CaBP33KaBP37 mixture with phospholipids was 
studied using lipasomes of different phospholipid com- 
position. No binding of the two proteins to lipasomes 
of phosphatidylcholine (PC) was detected, irrespective 
of the presence or absence of Ca2* (fig.2A). No binding 
was observed in the case of Iiposomes of phospha- 
tidylserine (PS), phosphatidylinositol (PI), or cardio- 
lipin (CL) in the absence of Ca*+ (fig.2A), whereas 
strong binding was registered in the presence of 0.1 mM 
free Ca2+ (fig.2A). The strongest binding was observed 
with CL liposomes (fig.2A). Thus we used CL lipo- 
somes to study the binding of the two proteins as a 
function of free Ca2+ concentration. No Ca2’-depen- 
dent precipitation of the two proteins was registered in 
the absence of liposomes (fig.2B, lanes ls,lp). Maximal 
binding was detected around 100 ,uM free Ca2, with 
half-maximal binding at - 10 pM free Ca” (fig.28, 
lanes 2s,2p-9s$p). The Ca’+-dependent binding of 
CaBP33 and CaBP37 to CL vesicles was completely 
reversed by EGTA (fig.2B, lanes lOs,lOp), Also, 
Ca2+-dependent binding of the two proteins to CL 
vesicles occurred even in the presence of 5 mM 
2-mer~aptoethanol (fig,2A,r)JU). Collectively, these 
data indicate that CaBP33 and CaBP37 are 
Ca’+-dependent phospholipid binding proteins. 
On the basis of these observations, we sought to 
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Fig.1. Characterization of CaBP33 and CaBP37. (a-c) SDS-PAGE of purified CaBP33 (a), purified CaBP37 (b), and CaBP33/CaBP37 mixture 
(c). (d-f) PAGE in the absence of SDS of S-1OOb protein (d), S-lOOa protein (e), and CaBP33KaBP37 mixture (f). (g-k’) SDS-PAGE (g-k) and 
immunoblots (g’-k’) of CaBP33/CaBP37 mixture (g,g’), bovine brain cytosol (h,h’), rat liver cytosol (i,i’), rat lung cytosol fjj’), and rat kidney 
cytosol (k,k’). (l-n’) SDS-PAGE (l-n) and immunoblots (II-n’) of bovine brain CaBP33KaBP37 mixture (l,l’), rat brain CaBP33 (m,m’), and 
porcine heart CaBP33/CaBP37 mixture (n,n’). (o-r’) SDS-PAGE (o-r) and immunoblots (o’-r’) of a partially purified preparation of bovine 
brain CaBP33KaBP37 mixture incubated for 5 min at 20°C (o,o’), 45°C (p,p’), 70°C (q,q’), or 100°C (r,r’). Proteins were cooled on ice and 
centrifuged. Samples of supernatants were analyzed by SDS-PAGE and immunoblotting. (s,t) Samples of CaBP33KaBP37 mixture boiled in 2% 
(w/v) SDS minus (s) or plus (t) 2% (w/v) t-mercaptoethanol prior to SDS-PAGE. (u-v’) Isolation of the CaBP33KaBP37 mixture from bovine 
brain by the procedure in [12]. SDS-PAGE (u-v) and immunoblots (u’ ,v’) of partially purified CaBP33 and CaBP37 (u,u’) and purified CaBP33 
and CaBP37 (v,v’). 
determine whether CaBP33 and CaBP37 also exist in a 
membrane-bound form and/or are capable of binding 
to brain membranes. Thus bovine brain tissue was 
homogenized in buffer I containing 1 mM CaC12, 0.25 
mM PMSF (buffer II) and centrifuged. The pellet was 
washed twice with buffer II, and resuspended in buffer 
II containing 0.1 M KC1 plus 1% (v/v) Triton X-100 
(buffer III). After 1 h at 4°C under agitation, the 
suspension was centrifuged. The supernatant (Triton 
X-lOO-extract) was saved, and the pellet was washed 
twice with buffer III minus Triton X-100 before extrac- 
tion with buffer I containing 5 mM EGTA (buffer IV). 
The suspension was centrifuged to obtain a supernatant 
(EGTA-extract) which was saved, and a pellet which 
was resuspended in buffer IV containing 0.9 M KCl. 
After 1 h at 4°C under agitation, the suspension was 
centrifuged to obtain a KCl-extract. All extracts were 
brought to 60% saturation with solid (NH&S04 and 
centrifuged. The supernatants were brought to 80% 
saturation with (NH&S04 and centrifuged. The pellets 
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were resuspended in minimal vols of buffer I and 
dialyzed against buffer I. The dialysates were centrifug- 
ed to remove insoluble material. These experiments 
were repeated in the absence of added CaClz and 
presence of 5 mM EGTA throughout. 
When bovine brain tissue was homogenized in the 
presence of added CaC12, BaCP33 and CaBP37 were 
recovered in all 3 membrane extracts (fig.3a-c,a’-c’). 
When bovine brain tissue was homogenized in the 
presence of EGTA, the two proteins were recovered ex- 
clusively in the Triton X-IOO-extract (fig.3d-f,d’-f’). 
Thus the two proteins can be induced to bind to brain 
membranes in the presence of Ca*+. Once the binding 
had occurred, a significant fraction of CaBP33 and 
CaBP37 resists extraction with Triton X-100, but it is 
not simply extractable with EGTA, suggesting that 
CaBP33 and CaBP37 interact strongly with Triton 
X-lOO-resistant (cytoskeletal?) membrane proteins 
through Ca’+, and that Ca2+ is no longer required for 
at least a fraction of these proteins to remain bound to 
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Fig.2. Binding of CaBP33 and CaBP37 to phospholipids. (A) Binding of the CaBP33ICaBP37 mixture to liposomes of different phospholipid com- 
position. Liposomes made of phosphatidylcholine (PC), phosphatidylserine (PS), phosphatidylinositol (PI), or cardiolipin (CL) were incubated 
at a concentration of 0.3 mg/ml with 10 fig of the CaBP33/CaBP37 mixture in 0.5 ml of 20 mM Tris-HCl, pH 7.5,0.1 M KCl, 1 mM MgCl2, 
1 mM EGTA in the absence (-) or presence (+) of 1.1 mM CaClr for 15 min at 20°C and centrifuged at 12000 x g for 10 min. Supernatants 
were saved, and pellets washed twice with the respective incubation buffer by resuspension and centrifugation. Individual final pellets were 
resuspended in 0.5 ml of 20 mM Tris-HCl, pH 7.5. Identical vols of supernatants ( ) and pellets (p) were analyzed by SDS-PAGE. Symbols (0, W) 
refer to results of experiments in which the binding of the CaBP33/CaBP37 mixture to CL vesicles was studied in the presence of 100 ,uM free 
Ca2+ in the absence (0) and presence (w) of 5 mM 2-mercaptoethanol. (B) Binding of the CaBP33/CaBP37 mixture to CL vesicles as a function 
of free Ca2+ concentration. Conditions were as described in (A), except hat binding was studied in the presence of increasing free Ca2+ concentra- 
tions: lanes 2(s,p), 0.5 ,uM; lanes 3(s,p), 1 pM; lanes 4(s,p), 5 PM; lanes 5(s,p), 1OpM; lanes 6(s,p), 50 CM; lanes 7(s,p), 1OO~M; lanes 8(s,p), 500 
PM; lanes 9(s,p), 1000,uM. Lanes l(s,p) refer to experiments in which the CaBP33/CaBP37 mixture was incubated at 1 mM free Ca2+ in the absence 
of liposomes. Lanes lO(s,p) refer to experiments in which the CaBP33/CaBP37 mixture was incubated with CL vesicles in the presence of 100/M 
free Ca2+ for 15 min, after which EGTA was added to 5 mM before centrifugation. Note that no Ca2+ .-Induced precipitation of the 
CaBP33/CaBP37 mixture occurs in the absence of liposomes, and that EGTA completely reverses the binding of these proteins to CL vesicles. 
(C) Plot of the CaBP33/CaBP37 bound to CL vesicles vs the free Ca2’ concentration. The amounts of CaBP33 and CaBP37 bound to CL vesicles 
(see B) were measured by densitometric scanning of SDS gels illustrated in (B). Results are expressed as the percentage of bound protein. 
their targets. Irrespective of the presence or absence of 
Ca2+ however, a substantial fraction of the two pro- 
teins is recovered in the Triton X-lOO-extract, pointing 
to a tight binding of the CaBP33KaBP37 mixture to 
the lipid bilayer and/or to intrinsic membrane proteins. 
This interaction seems to be Ca2+-independent or, alter- 
natively, Ca2+ is only required for this interaction to oc- 
cur. Future studies will dissect he molecular aspects of 
the complex binding of CaBP33 and CaBP37 to brain 
membranes. 
Since several requirements, namely Ca2+-dependent 
binding to phenyl-Sepharose [lo], to negatively charged 
phospholipids, and to natural membranes, are fulfilled, 
we suggest that CaBP33 and CaBP37 may be 
reasonably defined as brain annexins. Of course, final 
conclusions in this respect can be drawn once the 
primary sequences of the two proteins are available. 
Two proteins of A& values similar to those of CaBP33 
and CaBP37 have been identified in bovine brain using 
an antiserum against the 34 kDa calelectrin purified 
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Fig.3. Electrophoretic and immunological characterization of 
membrane-associated CaBP33 and CaBP37. Fractions to be analyzed 
for the presence of the CaBP33/CaBP37 mixture were obtained from 
bovine brain tissue as described in section 2. SDS-PAGE (a-f) and im- 
munoblots (a’-f’) of the Triton X-lOO-xtract (a,a’), the KCl-extract 
(b,b’), and the EGTA-extract (c,c’) from brain tissue obtained after 
homogenization in the presence of 1 mM CaC12, and of the Triton 
X-lOO-extract (d,d’), the KCl-extract (e,e’), and the EGTA-extract 
(f,f ‘) from bovine brain tissue obtained after homogenization in the 
presence of 5 mM EGTA. Note that the Triton X-lOO-extract contain 
the CaBP33/CaBP37 mixture irrespective of the homogenizing condi- 
tions, whereas the presence of CaCls during homogenization is a 
prerequisite for the two proteins to be recovered in the EGTA- and 
KCl-extracts. Similar experiments done in the presence of endogenous 
CaCls, i.e. no CaClr or EGTA added, gave the same results as in a-c, 
a’-~’ (data not shown). 
from Torpedo marmorata [16]. Although in principle 
we cannot exclude the possibility that we have purified 
and characterized brain calelectrins, we note the follow- 
ing. (i) The anti-calelectrin antiserum cross-reacts with 
two 32 and 34 kDa annexins that are abundant in 
bovine lung (70 mg/kg of tissue) [12], whereas no bin- 
ding of our antiCaBP33KaBP37 antiserum has been 
observed to polypeptides present in a rat lung cytosolic 
fraction. (ii) The antiCaBP33KaBP37 antiserum does 
not bind to the 67 kDa annexin found in the brain and 
liver [16] or to polypeptides of - 35 kDa in liver. It is 
known that the anti-34 kDa calelectrin antiserum and 
an antiserum raised against the 32.5 kDa calelectrin 
from liver and brain cross-react with the 67 kDa calelec- 
trin of liver and brain [16]. (iii) Contrary to the 34 kDa 
calelectrin which does not bind to liposomes in the 
presence of 1 mM 2-mercaptoethanol [ 171, CaBP33 and 
CaBP37 bind to negatively charged phospholipids and 
to brain membranes in the presence of 5 mM 2-mercap- 
toethanol. Also, changes in the electrophoretic mobility 
of the 34 kDa calelectrin in SDS gels has been reported 
when the protein was boiled in the absence of reducing 
agents [ 181, whereas no such changes have been observ- 
ed with CaBP33 and CaBP37 under the same condi- 
tions. (iv) Contrary to the 32.5 kDa calelectrin purified 
from liver and brain that precipitates at 70°C [16], our 
proteins are substantially heat-stable. Thus it can be 
reasonably concluded that we have identified and char- 
acterized novel brain Ca2+-dependent phospholipid- 
and membrane-binding proteins (annexins). 
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